Search results for: 'Infectious Disease Diagnostics Market'
- Did you mean
- infection disease diagnostics market
- Related search terms
- Markets and Markets
- Markets & Markets, Synthetic Biology – Global forecast to 2027, 2023. 01
- market analysis of rf energy harvesting technolog
- market+size+of+china's+overseas+marketing+industry
- market 08 00 00 00
-
23 Sep 2014  |  North America  |  Market Research
Analysis of the Global Infectious Disease Diagnostics Market
Molecular Methods Present Significant Opportunities
This deliverable provides research and analysis of the global infectious disease diagnostics market. It includes an in-depth analysis of revenue forecast by segment, drivers and restraints, and technology trends, along with the competitive factors and strategies, and key companies to watch. The global market is primarily driven by the high prevalen...
$3,950.00
Special Price $2,962.50 save 25 %
-
24 Feb 2016  |  North America  |  Market Research
US Autoimmune Disease Diagnostics Market, Forecast to 2020
Systemic Autoimmune Diseases to Spur Double-digit Market Growth as Participants Look to Unmet Needs and Game-changing Strategies to Boost Revenues
According to the National Institute of Health (NIH), there are more than 80 types of autoimmune diseases, of which less than 30 are diagnosable. Being 1 of the top 10 causes of death in the United States, there is a critical need in the market for the diagnosis and the treatment of both systemic diseases, such as lupus and rheumatoid arthritis, as ...
$1,500.00
Special Price $1,125.00 save 25 %
-
19 Dec 2022  |  North America  |  Market Research
PCR-based PoC Platforms for Infectious Disease Testing Growth Opportunities
Multimodal and Multiplex Platforms are Expanding the Molecular PoC Testing Ecosystem
Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...
$2,450.00
Special Price $1,837.50 save 25 %
-
31 Jul 2023  |  North America  |  Market Research
Global Oncology Diagnostics in IVD Growth Opportunities
By Leveraging Data-driven Solutions, Co-development Opportunities, and Assay Innovation, Clients Can Experience Enhanced Product Performance, Cost-effectiveness, and Improved Decision-making Capabilities
The global oncology diagnostics in IVD market is expected to witness significant growth, driven by an increase in cancer incidence, technological developments in diagnostic tests, the growing number of screening tests, and supportive government initiatives. Owing to the intense competition in the market, the most prominent companies are investing h...
$4,950.00
Special Price $3,712.50 save 25 %
-
05 Oct 2018  |  North America  |  Market Research
US Point-of-Care Testing Infectious Disease Market, Forecast to 2022
CLIA Waived Molecular POCT, Coupled with Upcoming Diseases Like Sepsis, Lyme Disease, New Strains of Influenza—H1, H3, and H7, will Drive Growth
Management of infectious diseases remains a critical challenge for public health professionals who face increasing demand to control the spread of existing and novel diseases. To provide appropriate healthcare assistance, it is imperative to diagnose the exact form of infection from an array of complicated symptoms expressed by the host. As the out...
$1,500.00
Special Price $1,125.00 save 25 %
-
14 Jul 2022  |  North America  |  Market Research
United States Molecular Point-of-Care Testing Growth Opportunities
Syndromic Point-of-Care Testing Drives Transformational Growth in Infectious Disease Diagnostics
Rapid advancements in infectious disease diagnostics continue with novel identification methods and healthcare accessibility improvements. The shift from traditional testing to a more technologically empowered, consumer-centric testing encompasses the sample-in-answer-out approach of diagnostic testing that generates results in minutes or hours. Nu...
$4,950.00
Special Price $3,712.50 save 25 %
-
14 Sep 2020  |  North America  |  Market Research
Smartphone-based Solutions Spur the Global Infectious Disease Point-of-Care Testing Market, Forecast to 2024
COVID-19 and STDs among Millennials Speed Development of Miniaturized POCT Devices and Alternate Care Sites to Enable Transformational Growth
The COVID-19 pandemic prompted a transformation in the infectious disease point-of-care testing (POCT) market. The shift towards miniaturized POCT devices will lead to the emergence of cost-effective integrated lab-on-a-chip devices based on microfluidic technologies and smartphone-based solutions enabling multiplexed detection of infectious pathog...
$4,950.00
Special Price $3,712.50 save 25 %
-
31 May 2013  |  North America  |  Market Research
Global Autoimmune Disease Diagnostics Market
This research service evaluates the global autoimmune disease diagnostics markets from 2009 to 2018. The market includes two segments, which include analysis for the markets for localized autoimmune disease diagnostic tests and for the systemic autoimmune disease diagnostic tests. This research service offers a discussion of the key market drivers ...
$4,950.00
Special Price $3,712.50 save 25 %
-
02 May 2018  |  North America  |  Technology Research
Breakthrough Innovations in PoC Diagnostics for Smart Healthcare
Rapid, Accessible, and Affordable Diagnostics Augmenting Healthcare
Today, the healthcare industry is focused toward patient centric care and preventative healthcare. Preventative healthcare involves regular screening and diagnosis for diseases before the condition becomes fatal. Early diagnosis improves the clinical outcome of the patients, reduces emergency visits, and subsequently healthcare costs. Usually, ear...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 May 2017  |  North America  |  Market Research
Growth Opportunities in the US In Vitro Diagnostics (IVD) Market, Forecast to 2021
US IVD Market Witnesses Pricing Fluctuations Due to the PAMA Regulation
The In Vitro Diagnostics (IVD) landscape in the United States is extremely dynamic, with a high level of merger and acquisition activity with many high-value deals still pending. Both clinical laboratories and manufacturers are increasingly vying for smaller specialized niche technology companies to increase their market share. Molecular point of c...
$4,950.00
Special Price $3,712.50 save 25 %